Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 83.3B | 101.5B | 113.5B | 117.5B |
Cost of revenue | — | — | — | — |
Gross profit | — | — | — | — |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 9.6B | 10.2B | 9.1B | 6.9B |
Other operating expenses | 8.8B | -25.4B | 19.6B | 22.0B |
Operating income | — | — | — | — |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 1.3B | 1.4B | 1.2B | 1.2B |
Other income expense | 13.6B | -22.3B | 24.8B | 26.1B |
Pretax income | 5.1B | 24.0B | 32.5B | 38.1B |
Tax provision | 476M | 4.3B | 6.0B | 7.6B |
Net income | 4.7B | 19.8B | 26.5B | 30.5B |
Basic EPS | 0.1 | — | 0.7 | 0.8 |
Diluted EPS | 0.1 | — | 0.7 | 0.8 |
Basic average shares | 28.1B | — | 28.1B | 28.1B |
Diluted average shares | 28.1B | — | 28.1B | 28.1B |
EBITDA | — | — | — | — |
Net income from continuing op. | 4.7B | 19.8B | 26.5B | 30.5B |
Minority interests | -69M | -57M | -229M | -150M |
Preferred stock dividends | — | — | — | — |